|
US1000470A
(en)
|
1908-02-11 |
1911-08-15 |
Frank C Widmann |
Ring-mold.
|
|
US1017295A
(en)
|
1910-08-20 |
1912-02-13 |
Adolph F Hensler |
Journal-box.
|
|
US1048588A
(en)
|
1911-05-05 |
1912-12-31 |
Adams & Westlake Co |
Pole-changer.
|
|
US1008080A
(en)
|
1911-07-15 |
1911-11-07 |
Jacub Schwartzman |
Bed-spring.
|
|
US1012404A
(en)
|
1911-07-29 |
1911-12-19 |
Frederick L S Means |
Protective caster.
|
|
US1044155A
(en)
|
1912-04-11 |
1912-11-12 |
Diamond Match Co |
Splint-drying means for match-machines.
|
|
US4367110A
(en)
|
1979-07-02 |
1983-01-04 |
Toppan Printing Co. |
Decorative laminate and a manufacturing method therefor
|
|
US4452901A
(en)
|
1980-03-20 |
1984-06-05 |
Ciba-Geigy Corporation |
Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
FR2504010B1
(fr)
|
1981-04-15 |
1985-10-25 |
Sanofi Sa |
Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
|
|
GB2097032B
(en)
|
1981-04-22 |
1984-09-19 |
Teron International Urban Dev |
A combined ceiling air and services distribution system mechanical chasse and structural roof member
|
|
US4478946A
(en)
|
1981-07-02 |
1984-10-23 |
South African Inventions Development Corporation |
Carrier bound immunosorbent
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
DE3377484D1
(en)
|
1982-04-19 |
1988-09-01 |
Nissan Motor |
Method for controlling reduction ratio of continuously variable transmission with acceleration compensation
|
|
US4818542A
(en)
|
1983-11-14 |
1989-04-04 |
The University Of Kentucky Research Foundation |
Porous microspheres for drug delivery and methods for making same
|
|
US4542225A
(en)
|
1984-08-29 |
1985-09-17 |
Dana-Farber Cancer Institute, Inc. |
Acid-cleavable compound
|
|
US4659839A
(en)
|
1984-10-10 |
1987-04-21 |
Mallinckrodt, Inc. |
Coupling agents for radiolabeled antibody fragments
|
|
ATE66469T1
(de)
|
1985-01-14 |
1991-09-15 |
Neorx Corp |
Metall-radionuklid markiertes protein fuer diagnose und therapie.
|
|
US5171582A
(en)
|
1985-07-31 |
1992-12-15 |
Ghent William R |
Treatment of iodine deficiency diseases
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
|
US5258499A
(en)
|
1988-05-16 |
1993-11-02 |
Vestar, Inc. |
Liposome targeting using receptor specific ligands
|
|
US5260422A
(en)
|
1988-06-23 |
1993-11-09 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US6106840A
(en)
|
1988-06-23 |
2000-08-22 |
Anergen, Inc. |
MHC conjugates useful in ameliorating autoimmunity
|
|
US4859839A
(en)
|
1988-07-08 |
1989-08-22 |
Counter Computer Corporation |
Point-of-sale terminal for laundry or dry cleaning establishments
|
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
|
DE69232875T2
(de)
|
1991-04-23 |
2003-08-21 |
Anergen, Inc. |
MHC-Konjugate zur Verbesserung der Autoimmunität.
|
|
US5200189A
(en)
|
1991-07-23 |
1993-04-06 |
Ecolab Inc. |
Peroxyacid antimicrobial composition
|
|
WO1993016725A1
(en)
|
1992-02-27 |
1993-09-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Early antigen for autoimmune diabetes
|
|
JP2631436B2
(ja)
|
1992-07-24 |
1997-07-16 |
徳厚 小島 |
排水立て管継手
|
|
US5972336A
(en)
|
1992-11-03 |
1999-10-26 |
Oravax Merieux Co. |
Urease-based vaccine against helicobacter infection
|
|
CN1148812A
(zh)
|
1994-03-28 |
1997-04-30 |
尼科梅德成像有限公司 |
“脂质体”
|
|
US6103379A
(en)
|
1994-10-06 |
2000-08-15 |
Bar-Ilan University |
Process for the preparation of microspheres and microspheres made thereby
|
|
WO1996018105A1
(en)
|
1994-12-06 |
1996-06-13 |
The President And Fellows Of Harvard College |
Single chain t-cell receptor
|
|
DE19508058A1
(de)
|
1995-02-21 |
1996-08-22 |
Schering Ag |
Verfahren zur Herstellung von DTPA-Tetraestern der terminalen Carbonsäuren und deren Verwendung zur Herstellung pharmazeutischer Mittel
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US6033864A
(en)
|
1996-04-12 |
2000-03-07 |
The Regents Of The University Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
|
|
DK0935607T3
(da)
|
1996-08-16 |
2004-12-06 |
Harvard College |
Oplöselige monovalente og multivalente MHC klasse II-fusionsproteiner samt anvendelser deraf
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
AU741130B2
(en)
|
1997-09-16 |
2001-11-22 |
Oregon Health Sciences University |
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
|
|
BR9908082A
(pt)
|
1998-02-19 |
2000-10-31 |
Harvard College |
Proteìna de fusão do complexo de histocompatibilidade principal classe ii, conjugado dos domìnios de ligação do complexo de histocompatibilidade principal multimérico, processos para detectar células t tendo uma especificidade do complexo definido de mhc / peptìdeo, para conferir a um indivìduo imunidade adotiva a um complexo definido de mhc / peptìdeo, para estimular ou ativar as células t reativas a um complexo definido de mhc / peptìdeo, para seletivamente matar células t reativas a um complexo definido de mhc / peptìdeo, para tolerizar um indivìduo humano a um complexo definido de mhc / peptìdeo, e, ácido nucleico isolado
|
|
EP1094828A4
(en)
|
1998-05-07 |
2005-01-26 |
Univ California |
USE OF TARGETED, NEGLIGATED TISSUE ANTIGENS TO MODULATE IMMUNE REACTIONS
|
|
DE19825371A1
(de)
|
1998-06-06 |
1999-12-09 |
Bayer Ag |
Elektrochrome Anzeigevorrichtung mit isolierten Zuleitungen
|
|
IL125608A0
(en)
|
1998-07-30 |
1999-03-12 |
Yeda Res & Dev |
Tumor associated antigen peptides and use of same as anti-tumor vaccines
|
|
US7807377B2
(en)
*
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
US6150022A
(en)
|
1998-12-07 |
2000-11-21 |
Flex Products, Inc. |
Bright metal flake based pigments
|
|
JP2000213425A
(ja)
|
1999-01-20 |
2000-08-02 |
Hino Motors Ltd |
Ｅｇｒク―ラ
|
|
US7090973B1
(en)
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
|
AU4825700A
(en)
|
1999-05-06 |
2000-11-21 |
Genetics Institute Inc. |
Use of soluble costimulatory molecules to enhance immune responses
|
|
AU784551B2
(en)
|
1999-10-06 |
2006-05-04 |
Trustees Of The University Of Pennsylvania, The |
Cell targeting compositions and methods of using the same
|
|
US6585947B1
(en)
|
1999-10-22 |
2003-07-01 |
The Board Of Trustess Of The University Of Illinois |
Method for producing silicon nanoparticles
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
KR100379250B1
(ko)
|
2000-12-04 |
2003-04-08 |
한국과학기술연구원 |
나노 단위 크기의 금속 입자가 함유된 고분자 복합 소재및 그 제조 방법
|
|
WO2002080963A1
(en)
|
2001-04-05 |
2002-10-17 |
Virginia Mason Research Center |
Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment
|
|
DE10117858A1
(de)
|
2001-04-10 |
2002-10-24 |
Gsf Forschungszentrum Umwelt |
MHC-Tetramere
|
|
US20070129307A1
(en)
|
2001-06-22 |
2007-06-07 |
The University Of British Columbia |
Insulin epitopes for the treatment of type 1 diabetes
|
|
JP2004532896A
(ja)
|
2001-06-22 |
2004-10-28 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
Ｉ型糖尿病の診断及び治療
|
|
US20030124149A1
(en)
|
2001-07-06 |
2003-07-03 |
Shalaby Shalaby W. |
Bioactive absorbable microparticles as therapeutic vaccines
|
|
JP2005511761A
(ja)
|
2001-07-10 |
2005-04-28 |
ノース・キャロライナ・ステイト・ユニヴァーシティ |
ナノ粒子送達ビヒクル
|
|
DE10144252A1
(de)
|
2001-08-31 |
2003-03-27 |
Fraunhofer Ges Forschung |
Nanopartikel mit daran immobilisiertem biologisch aktivem TNF
|
|
CA2466656C
(en)
|
2001-11-09 |
2013-07-02 |
Nanosphere, Inc. |
Bioconjugate-nanoparticle probes
|
|
EP1581119B1
(en)
|
2001-12-17 |
2013-01-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
|
US6688494B2
(en)
|
2001-12-20 |
2004-02-10 |
Cima Nanotech, Inc. |
Process for the manufacture of metal nanoparticle
|
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
US20040115216A1
(en)
|
2002-07-12 |
2004-06-17 |
The Johns Hopkins University |
Reagents and methods for engaging unique clonotypic lymphocyte receptors
|
|
DE10310261A1
(de)
|
2003-03-05 |
2004-09-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Identifizierung von Antigen-Epitopen
|
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
|
US6929675B1
(en)
|
2003-04-24 |
2005-08-16 |
Sandia Corporation |
Synthesis metal nanoparticle
|
|
US20050118102A1
(en)
|
2003-04-28 |
2005-06-02 |
Intematix Corporation |
Spin resonance heating and/or imaging in medical applications
|
|
WO2004104185A1
(en)
|
2003-05-08 |
2004-12-02 |
Xcyte Therapies, Inc. |
Generation and isolation of antigen-specific t cells
|
|
US8758767B2
(en)
|
2003-05-20 |
2014-06-24 |
Albert Einstein College Of Medicine Of Yeshiva University |
Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof
|
|
US7060121B2
(en)
|
2003-06-25 |
2006-06-13 |
Hsing Kuang Lin |
Method of producing gold nanoparticle
|
|
WO2005007673A2
(en)
|
2003-07-03 |
2005-01-27 |
Rush University Medical Center |
Immunogenic peptides
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
GB0321937D0
(en)
|
2003-09-19 |
2003-10-22 |
Univ Liverpool |
Nanoparticle conjugates and method of production thereof
|
|
CN1864020B
(zh)
|
2003-10-09 |
2014-03-05 |
布鲁克斯仪器有限责任公司 |
阀组件
|
|
DE102004023187A1
(de)
|
2004-05-11 |
2005-12-01 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
|
WO2006080951A2
(en)
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
ES2625905T3
(es)
|
2004-10-01 |
2017-07-20 |
Midatech Ltd. |
Nanopartículas que comprenden antígenos y adyuvantes capaces de estimular linfocitos T cooperadores
|
|
WO2006054806A1
(ja)
|
2004-11-22 |
2006-05-26 |
Locomogene, Inc. |
クローン病関連自己抗原
|
|
US7462446B2
(en)
|
2005-03-18 |
2008-12-09 |
University Of Washington |
Magnetic nanoparticle compositions and methods
|
|
US20070059775A1
(en)
|
2005-03-29 |
2007-03-15 |
The Trustees Of Columbia University In The City Of New York |
Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and MR imaging techniques
|
|
US7562421B2
(en)
|
2005-04-03 |
2009-07-21 |
Magen Eco Energy A.C.S. Ltd. |
Connecting clasp
|
|
US7326399B2
(en)
|
2005-04-15 |
2008-02-05 |
Headwaters Technology Innovation, Llc |
Titanium dioxide nanoparticles and nanoparticle suspensions and methods of making the same
|
|
WO2007024026A1
(ja)
|
2005-08-25 |
2007-03-01 |
Taiho Pharmaceutical Co., Ltd. |
Ｔ細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
|
|
US9393215B2
(en)
|
2005-12-02 |
2016-07-19 |
Novartis Ag |
Nanoparticles for use in immunogenic compositions
|
|
US20100061984A1
(en)
|
2006-01-20 |
2010-03-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for modulation of suppressor t cell activation
|
|
WO2008017517A1
(en)
|
2006-08-11 |
2008-02-14 |
Life Sciences Research Partners Vzw |
Immunogenic peptides and their use in immune disorders
|
|
US7816814B1
(en)
|
2006-08-18 |
2010-10-19 |
Hennessy Michael J |
Bi-directional power converters
|
|
CA2674632A1
(en)
|
2006-12-29 |
2008-07-10 |
University Of Washington |
Dual-functional nonfouling surfaces and materials
|
|
WO2008115641A2
(en)
|
2007-02-15 |
2008-09-25 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
|
JP5650406B2
(ja)
|
2007-03-07 |
2015-01-07 |
ユーティーアイ リミテッド パートナーシップ |
自己免疫状態の予防および治療のための組成物および方法
|
|
US20150250871A1
(en)
|
2007-03-07 |
2015-09-10 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
US20140105980A1
(en)
|
2012-10-11 |
2014-04-17 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
US20100151031A1
(en)
|
2007-03-23 |
2010-06-17 |
Desimone Joseph M |
Discrete size and shape specific organic nanoparticles designed to elicit an immune response
|
|
WO2009003493A2
(en)
*
|
2007-07-03 |
2009-01-08 |
Dako Denmark A/S |
Mhc multimers, methods for their generation, labeling and use
|
|
US8666532B2
(en)
|
2007-07-22 |
2014-03-04 |
Camtek Ltd. |
Method and system for controlling a manufacturing process
|
|
JP5085240B2
(ja)
|
2007-09-03 |
2012-11-28 |
日本電波工業株式会社 |
水晶デバイス及び水晶デバイスの製造方法
|
|
JP5624471B2
(ja)
|
2007-09-24 |
2014-11-12 |
バーイラン ユニバーシティー |
磁性金属酸化物で被覆されたポリマー性ナノ粒子及びその使用
|
|
WO2009064273A1
(en)
|
2007-11-16 |
2009-05-22 |
Paul Appelbaum |
Apparatus and method for packaging articles in clear plastic packages
|
|
WO2009078799A1
(en)
|
2007-12-17 |
2009-06-25 |
Marfl Ab |
New vaccine for the treatment of mycobacterium related disorders
|
|
US8629098B2
(en)
|
2008-01-15 |
2014-01-14 |
Yale University |
Compositions and methods for adoptive and active immunotherapy
|
|
CA2717719A1
(en)
|
2008-02-04 |
2009-08-13 |
David G. Fernig |
Nanoparticle conjugates
|
|
US20110151015A1
(en)
|
2008-03-04 |
2011-06-23 |
Liquikia Technologies, Inc. |
Immunomodulator particles and methods of treating
|
|
WO2009126835A2
(en)
|
2008-04-09 |
2009-10-15 |
University Of Washington Techtransfer Invention Licensing |
Magnetic nanoparticle and method for imaging t cells
|
|
US20090258355A1
(en)
|
2008-04-11 |
2009-10-15 |
Brookhaven Science Associates, Llc |
Nanoscale Clusters and Methods of Making Same
|
|
WO2010098788A2
(en)
|
2008-08-25 |
2010-09-02 |
Amplimmune, Inc. |
Pd-i antagonists and methods for treating infectious disease
|
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
WO2010037397A1
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cmv immune monitoring
|
|
WO2010037395A2
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
CA2642141A1
(en)
|
2008-10-20 |
2010-04-20 |
Innovative Microelectronics Inc. |
Flange alignment pin
|
|
EP2353004B1
(en)
|
2008-11-12 |
2018-01-03 |
Yeda Research and Development Co. Ltd. |
Diagnosis of multiple sclerosis
|
|
WO2010080032A2
(en)
|
2009-01-09 |
2010-07-15 |
Stichting Het Nederlands Kanker Instituut |
Bead-assisted viral transduction
|
|
MX2011007559A
(es)
|
2009-01-20 |
2011-12-06 |
Myelin Repair Foundation Inc |
Composiciones y metodos para induccion de tolerancia antigeno-especifica.
|
|
US8383085B2
(en)
|
2009-05-29 |
2013-02-26 |
University Of Manitoba |
Methods of making iron-containing nanoparticles
|
|
WO2011044186A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
|
GB0922066D0
(en)
|
2009-12-17 |
2010-02-03 |
Univ Belfast |
Modulator
|
|
GB201003088D0
(en)
|
2010-02-24 |
2010-04-14 |
Univ Exeter |
Method for the preparation of a novel nanoparticle conjugate
|
|
PL2598165T3
(pl)
|
2010-07-26 |
2018-02-28 |
Qu Biologics Inc. |
Immunogenne kompozycje przeciwzapalne
|
|
WO2012025936A2
(en)
|
2010-08-25 |
2012-03-01 |
Ramamohan Rao Davuluri |
Improved process for the preparation of rufinamide
|
|
WO2012031258A1
(en)
|
2010-09-03 |
2012-03-08 |
Oregon Health & Science University |
Recombinant t-cell receptor ligands with covalently bound peptides
|
|
BR112013007069A2
(pt)
|
2010-09-29 |
2016-09-13 |
Uti Limited Partnership |
métodos para tratar doença autoimune usando nanoesferas biocompatíveis e bioabsorvíveis
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
JP6077544B2
(ja)
|
2011-09-07 |
2017-02-08 |
ミダテック リミテッド |
ナノ粒子−ペプチド組成物
|
|
WO2013043662A1
(en)
|
2011-09-22 |
2013-03-28 |
Marv Enterprises Llc |
Method for the treatment of multiple sclerosis
|
|
EP2591801A1
(en)
|
2011-11-14 |
2013-05-15 |
Universitätsklinikum Hamburg-Eppendorf |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
|
|
CN102376225B
(zh)
|
2011-11-18 |
2013-09-04 |
深圳市华星光电技术有限公司 |
平板显示装置、立体显示装置以及等离子显示装置
|
|
US10758487B2
(en)
|
2011-12-09 |
2020-09-01 |
The Johns Hopkins University |
Artificial antigen presenting cells having a defined and dynamic shape
|
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
|
WO2013184976A2
(en)
|
2012-06-06 |
2013-12-12 |
Northwestern University |
Compositions and methods for antigen-specific tolerance
|
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
JP6475167B2
(ja)
|
2012-12-21 |
2019-02-27 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ジスルフィド結合した多価ｍｈｃクラスｉを含む多機能タンパク質
|
|
US9335768B2
(en)
|
2013-09-12 |
2016-05-10 |
Lam Research Corporation |
Cluster mass flow devices and multi-line mass flow devices incorporating the same
|
|
SG10201803780UA
(en)
|
2013-11-04 |
2018-06-28 |
Uti Lp |
Methods and compositions for sustained immunotherapy
|
|
EP3160453A1
(en)
|
2014-06-25 |
2017-05-03 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
|
JP6718450B2
(ja)
|
2014-12-19 |
2020-07-08 |
イーティーエッチ チューリッヒ |
キメラ抗原受容体及びその使用方法
|
|
EP3067366A1
(en)
|
2015-03-13 |
2016-09-14 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
|
|
BR112017020750A2
(en)
|
2015-03-27 |
2018-06-26 |
President And Fellows Of Harvard College |
modified t-cells and methods of producing and using them
|
|
ES3055030T3
(en)
|
2015-05-06 |
2026-02-09 |
Uti Lp |
Nanoparticle compositions for sustained therapy
|
|
MA44907A
(fr)
|
2015-09-11 |
2018-07-18 |
Agenus Inc |
Cellules hôtes génétiquement modifiées et leurs procédés d'utilisation
|
|
US20180127481A1
(en)
|
2016-11-09 |
2018-05-10 |
Uti Limited Partnership |
RECOMBINANT pMHC CLASS II MOLECULES
|
|
SG11201909290TA
(en)
|
2017-04-07 |
2019-11-28 |
Uti Lp |
Assay to measure the potency of receptor-ligand interactions in nanomedicines
|
|
EP3716949A4
(en)
|
2017-11-29 |
2022-05-18 |
UTI Limited Partnership |
METHODS OF TREATMENT OF AUTOIMMUNE DISEASES
|